THC (Tenet Healthcare Corporation New) Stock Analysis - Analyst Ratings

Tenet Healthcare Corporation New (THC) is a publicly traded Healthcare sector company. As of May 20, 2026, THC trades at $187.38 with a market cap of $16.58B and a P/E ratio of 12.05. THC moved -1.88% today. Year to date, THC is -9.47%; over the trailing twelve months it is +11.12%. Its 52-week range spans $109.82 to $247.21. Analyst consensus is strong buy with an average price target of $248.27. Rallies surfaces THC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate THC?

15 analysts cover THC: 0 strong buy, 14 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $248.27.

THC Key Metrics

Key financial metrics for THC
MetricValue
Price$187.38
Market Cap$16.58B
P/E Ratio12.05
EPS$15.61
Dividend Yield0.00%
52-Week High$247.21
52-Week Low$109.82
Volume1.58M
Avg Volume0
Revenue (TTM)$21.31B
Net Income$2.37B
Gross Margin0.00%

THC Analyst Consensus

15 analysts cover THC: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $248.27.

Latest THC News

Recent THC Insider Trades

  • Arbour Paola M sold 6.50K (~$1.55M) on Mar 11, 2026.
  • Arnst Thomas W sold 4.71K (~$1.12M) on Mar 9, 2026.
  • Arnst Thomas W sold 3.29K (~$786.87K) on Mar 9, 2026.

Common questions about THC

What do analysts rate THC?
15 analysts cover THC: 0 strong buy, 14 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $248.27.
Does Rallies show THC price targets?
Yes. Rallies tracks THC analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is THC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for THC. It does not provide personalized investment advice.
THC

THC